Related Experiment Videos
Functional abnormalities in vincristine-induced night blindness.
Investigative Ophthalmology & Visual Science
|July 1, 1984
Summary
Vincristine chemotherapy caused night blindness by disrupting synaptic transmission in the retina, mimicking inherited night blindness. This suggests a specific drug-induced retinal dysfunction affecting photoreceptor communication.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Vincristine chemotherapy can cause visual disturbances, including night blindness.
- Stationary night blindness is a group of inherited retinal disorders.
- Retinal function is typically assessed using noninvasive tests like electroretinography (ERG).
Observation:
- A patient undergoing vincristine chemotherapy developed night blindness.
- Noninvasive tests revealed a monophasic dark-adaptation curve, normal rhodopsin kinetics, and residual rod vision.
- The electroretinogram (ERG) showed a depressed b-wave with normal a-wave potentials.
Findings:
- The patient's retinal function test results closely resembled those of recessively inherited stationary night blindness.
- Vincristine's known effect on neuronal microtubules suggests a mechanism for the observed visual defect.
- The findings point to impaired synaptic transmission between retinal photoreceptors and second-order neurons.
Implications:
- Vincristine-induced visual impairment may result from a specific defect in retinal synaptic function.
- Understanding this mechanism could lead to strategies for mitigating chemotherapy-related visual side effects.
- This case highlights the importance of monitoring retinal function during vincristine treatment.